However, in the East Asian population, no statistically significant evidence was observed to support these associations.<h4>Conclusions</h4>This study provided genetic evidence that Lp(a) may be a causal factor for AF and that LPA may represent a promising pharmacological target for preventing AF in the European population. This evidence concerns the gene LPA and atrial fibrillation.